TNBC
2 stories
-
healthNew TNBC Study Reveals Drug-Resistant Cell States After Chemo
Researchers identify four distinct drug-tolerant cell states in triple-negative breast cancer, offering new targets to prevent recurrence.
-
healthPersonalized mRNA Vaccines Show Durable T Cell Immunity Against TNBC
New research demonstrates individualized mRNA neoantigen vaccines successfully induce robust and lasting T cell responses in patients with triple-negative breast cancer (TNBC), offering a promising therapeutic avenue.